Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised …
…, WRJ Taylor, V Chotivanich, K Chotivanich… - The Lancet Infectious …, 2024 - thelancet.com
Background Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19
antiviral treatments, but their antiviral activities in patients have not been compared …
antiviral treatments, but their antiviral activities in patients have not been compared …
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
…, WRJ Taylor, V Chotivanich, K Chotivanich… - BMC Infectious …, 2024 - Springer
Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …
Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)
…, M Imwong, WRJ Taylor, V Chotivanich… - The Journal of …, 2023 - academic.oup.com
Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Background: There is no generally accepted methodology for in vivo assessment of antiviral
activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a treatment …
activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a treatment …
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a …
…, K Poovorawan, M Mayxay, K Chotivanich… - The Lancet Infectious …, 2024 - thelancet.com
Background Effective antiviral drugs prevent hospitalisation and death from COVID-19.
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …
Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants
…, K Poovorawan, M Imwong, WRJ Taylor, V Chotivanich… - medRxiv, 2022 - medrxiv.org
Background Uncertainty over the therapeutic benefit provided by parenteral remdesivir in
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …
Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19
Background There is no generally accepted methodology for in vivo assessment of antiviral
activity in SARS-CoV-2 infection. Ivermectin has been recommended widely as a treatment …
activity in SARS-CoV-2 infection. Ivermectin has been recommended widely as a treatment …
Quality of Life in Breast Cancer Patients
…, W Kasetsermviriya, S Srimantayamas, V Chotivanich - 2010 - pesquisa.bvsalud.org
Abstract Quality of Life in Breast Cancer Patients Suphakan Techapongsatorn MD, FICS*
Supada Techapongsatorn MD** Wisit Kasetsermviriya MD* Satit Srimantayamas MD* Vasin …
Supada Techapongsatorn MD** Wisit Kasetsermviriya MD* Satit Srimantayamas MD* Vasin …
A Comparative Study between Compressible Brassiere and Conventional Pressure Dressing for Seroma Prevention after Mastectomy in Breast Cancer
…, W Kasetsermviriya, S Srimantayamas, V Chotivanich… - 2010 - pesquisa.bvsalud.org
… FICS Wisit Kasetsermviriya MD Satit Srimantayamas MD Vasin Chotivanich MD Anan
Manomaipiboon MD, MSc, FICS Department of Surgery, BMA Medical College and Vajira Hospital …
Manomaipiboon MD, MSc, FICS Department of Surgery, BMA Medical College and Vajira Hospital …
Risk factors associated with inguinal hernia in adult male: a case-control study
A Manomaipiboon, S Ampornareekul, V Chotivanich… - 2010 - pesquisa.bvsalud.org
Abstract Risk Factors associated with Inguinal Hernia in Adult Male A Case-control Study
Anan Manomaipiboon MD, MSc (Clinical Epidemiology)* Sawit Ampornareekul MD** Vasin …
Anan Manomaipiboon MD, MSc (Clinical Epidemiology)* Sawit Ampornareekul MD** Vasin …
